Ravulizumab Clinical Trials

4 actively recruiting trials across 2 locations

No change since May 2026

Also known as: Ultomiris

Pipeline

Phase 2: 1Phase 4: 1

Top Sponsors

Alexion Pharmaceuticals, Inc.2
Mayo Clinic1
AstraZeneca1

Indications

Cancer3
Generalized Myasthenia Gravis2
Liver Disease1
Preeclampsia1
gMG1

Other2 trials

Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis

Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis

Chicago, Illinois1 trial

A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

Research Site

Phase 4

Rochester, Minnesota1 trial

Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders

Mayo Clinic Minnesota

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.